Hints and tips:
Related Special Reports
...But the companies do not have a history of protein manufacturing used by Novo Nordisk and its US rival Eli Lilly to make their diabetes and weight-loss products....
...Tirzepatide — the active ingredient behind Eli Lilly’s diabetes treatment Mounjaro and weight loss drug Zepbound — is also produced by WuXi Biologics, according to two people familiar with the matter....
...and dramatic weight-loss results boosting demand....
...And weight loss drugs like Ozempic have been in the news a lot. But are we missing their true potential?...
...loss than previous medicines....
...Novo Holdings readies its M&A machine Novo Nordisk has become Europe’s largest company on the back of sales of weight loss and diabetes drugs Wegovy and Ozempic....
...company entered the race to develop an obesity drug, signing a licensing agreement with Chinese company Eccogene to develop an oral obesity pill, in contrast to Eli Lilly and Novo Nordisk’s injectable weight-loss...
...Another version followed in 2015, targeting weight loss. But it only helped patients lose about 5 per cent of their body weight....
...And the history of 2007 — and 2001 — suggests that if anything causes the hype around tech innovation to crack, there could be a contagious loss of faith that hurts many investors....
...These are the new generation of weight loss and diabetes drugs that have just shown a much more significant weight loss than any previous obesity treatment....
...Other innovations this year also hold promise. The regulatory approval of weight-loss drugs — such as Novo Nordisk’s Wegovy — could help to lower healthcare burdens....
...The exchange also reported $273mn in net income for the quarter, reversing the $79mn loss reported at the start of the year....
...German pharma group Boehringer Ingelheim and Copenhagen-based Zealand Pharma said their weight-loss drug had achieved positive results in liver disease trials....
...Novo Nordisk, which makes weight loss and diabetes drugs Wegovy and Ozempic, said innovation increasingly came from smaller start-up companies that would struggle to get funding if the new plan was adopted...
...Complaining that central bankers are squeezing borrowers is a bit like grumbling that weight-loss drugs are making your face look gaunt. Looking pinched is part of the process....
...Referencing Cathie Wood’s high-profile Ark Innovation ETF, Kashner said “people are willing to pay up for ARKK, JEPI etc....
...The rising use of medications for weight loss has sparked supply fears for diabetics’ drugs....
...The success of weight loss drugs from Novo Nordisk and Eli Lilly has prompted other invidious comparisons. Roche is therefore acquiring US-based obesity drugs developer Carmot for up to $3.1bn....
...Some good news New trial data suggests weight-loss drug Wegovy could also address aspects of heart disease....
...The pharmaceutical company had not yet launched Ozempic, the diabetes drug that would later become famous as celebrities took it off-label for weight loss, and was years from the approval of Wegovy, the...
...Such is their size, their legs often cannot support their weight....
...Such breakthroughs as cancer immunotherapy, Covid vaccines and weight-loss drugs have improved the odds since then....
...But in May, the safety issue resurfaced when the World Health Organization recommended that non-sugar sweeteners should not be used to support weight loss or the maintenance of healthy blood glucose levels...
...FT innovation editor John Thornhill and producer Persis Love ask whether we’re moving closer to being able to “speak whale” or even to chat with bats....
...In robust physical shape for his age, he also suffered from periodic lapses of memory and (possibly strategic) loss of hearing....
International Edition